Key result
This editorial reviews the 2017 publication metrics and highlights of the EP Europace Journal, outlining future strategic directions under the new Editor-in-Chief.
Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This editorial outlines the achievements of the EP Europace Journal in 2017 and its strategic direction under new leadership.
Dear colleagues, readers, and friends, As you may know, I have taken over the position of Editor-in-Chief of the EP Europace Journal in 2017 as the successor of Prof John Camm. This is both a big honour and a challenge for me. First of all, I would like to take this opportunity to thank John Camm and the whole Editorial Team for handing over a journal which is a rising star in the field of arrhythmias and electrophysiology. Due to the dedicated and hard work of the team, the Journal has advanced among the top three sub-speciality journals in the field. The Journal currently has an impact factor of 4.52 and a sharply increasing submission rate of manuscripts from all around the world confirming the recognition of its top position in the field of scientific and educational publications. In 2017, we have seen an all-time high of more than 1300 manuscript submissions. This gives us a huge opportunity to further develop the Journal. With this Editorial, I would like to briefly review the 2017 publication metrics, the highlights, and some of the most interesting manuscripts that we have published within the last 12 months and also share with you my strategic thoughts how to best meet the needs and expectations of our readership in the future. Looking back: the Year 2017 in the EP Europace Journal: Overall, we have published more than 600 original papers, documents, editorials, letters, and case reports in 2017. It is interesting to look at the key topics or the key focus of the manuscripts published: the field is headed by around 258 papers covering science and education related to atrial fibrillation with a focus on ablation therapy (127 papers) and anticoagulation aspects (27 papers). The other key focus fields of interest were: ventricular tachycardia (62 papers) with ventricular ablation aspects addressed in 36 papers; sudden cardiac death (51 papers) and arrhythmias in heart failure with 89 papers. Cardiac implantable electronic devices continued to play a major role with 79 papers from the field of implantable loop recorders/pacemakers, 72 papers for defibrillator therapy, and 59 papers for cardiac resynchronization therapy. Genetics/channelopathies/Brugada syndrome with 45 papers and syncope with 28 papers complete the wide spectrum of themes and topics covered in 2017. European Heart Rhythm Association (EHRA) documents: We are proud to be the official journal of the EHRA and the main publication platform for the official EHRA documents. In 2017, we have published a total of 24 EHRA documents or EHRA-related documents of utmost importance and significance such as the new atrial fibrillation ablation consensus document,1 the document of hypertension and cardiac arrhythmias,2 and the very important document on antithrombotic therapy for patients with atrial fibrillation and valvular heart disease.3 Indeed, these documents did not only summarize the current knowledge and provide state-of-the-art treatment standards and recommendations but also induced high level and sometimes controversy discussions about their interpretation as well as on the needs and requirements for future scientific studies.4,5 The EHRA Scientific Initiatives Committee continued collecting important data on recent trends in the world of electrophysiology, and the EP Europace Journal was the first in the field to publish data indicating changes in the implantation behaviour for primary prevention in non-ischaemic cardiomyopathy as a result of the recently published DANISH Trial.6,7 Another highlight from 2017 was certainly the 10th Edition of the EHRA White Book, the one and only real footprint of European electrophysiology for a decade now.8 For the first time ever, the EP Europace Journal published statistics on the availability and utilization of cardiac implantable electronic devices in Africa obtained by PASCAR, the Pan-African Society of Cardiology.9 We are particularly proud on this publication and would be happy to extend our partnership with African electrophysiologists, associations, and societies.10 Overall, I think that we have published high quality science, education, and consensus documents with the right balance among the topics in our field. Looking ahead: The Journal’s future focus: What are the main developments of interest and significance in the field of arrhythmias and heart rhythm disturbances? I believe that atrial fibrillation, ventricular tachycardia, and the close connection between rhythm disturbances and heart failure will continue playing a key role. We will continue to focus on clinical electrophysiology with high quality research and education. Indeed, we will continue our steady efforts to raise our attractivity for clinical trials and innovative techniques and technologies. Thus, we will encourage the top clinicians and scientists in the field to submit their ideas, study results, and clinical trials to us. Time lines from submission to publication are very important to attract top research. We will further streamline our manuscript handling and also introduce the opportunity for Fast Track publication in the Journal. At the same time, we will not forget the significant role of basic research for the progress in our field, and we will focus on basic science manuscripts with a clear translational message. Editorials from key opinion leaders will help the clinician to find the clinical perspective paved out in basic research papers published with us. The environment for scientific publication is changing—very fast! (Figure 1). More and more ‘medical’ journals mainly introduced via the internet appear on the stage, most of them with dubious background, profit goals, and no visible scientific standards. We will stay firm in the promotion of high publication standards as our quality seal and as a strong differentiation marker from such journals. Moreover, traditional scientific publication using classical print media is increasingly supplemented by online products and the strong and increasing influence of social media. I see that as a significant chance and opportunity as the digital world and the internet offer additional platforms for the transmission of messages, data, and information that can be prepared creatively in various formats such as animations, videos, serious games, podcasts, and connected communities. Together with our partners from the EHRA and from our publisher and hand in hand with the other members of the ESC Journal family, we will increase our activities and our visibility in this field. And you, our readership, are invited and needed to support us in this particular activity: ‘Make some scientific and educational noise’ around the articles published in the EP Europace Journal to increase our recognition. It is important for the future rating and ranking of the Journal as traditional citation metrics such as the impact factor or the h-index may be more and more supplemented by novel ‘traffic’-related metrics. Needless to say, the impact factor is still the ‘ejection fraction of the Journal’, familiar to everyone and generally considered to be the most important strength marker of a journal quite comparable to the role that left ventricular ejection fraction plays in cardiovascular medicine (Figure 2). However, as ejection fraction is just one piece of the mosaic in cardiovascular medicine, the impact factor is just one perspective on a journal—and not the only one. Nevertheless, despite all importance that the new media and communication tools may already have, we will stay firm in our principles and in avoiding superficial activities just for the sake of publicity. ‘Make some noise’! Non-traditional metrics as a measure of ‘impact’ and mainly based on the ‘traffic’ generated by a paper or a journal in the social media are coming up. It is important to understand that the ‘social media impact’ can be much different from the scientific impact measured by traditional metrics such as citations. This becomes obvious by looking to the top ranked medical papers in Altmetric Top 100 list.11 The ‘ejection fraction’ of traditional scientific publication: the impact factor of EP Europace Journal over the last years documents the huge success for the journal. Thanks to the great work of Prof John Camm, the journals Editor-in-Chief from 2007 to 2017, his Editorial Board, and the publication team. New non-traditional citation metrics such as Altmetric include multiple sources of ‘traffic’ for their rating including HTML views and PDF downloads, discussions in journal comments, science blogs, Wikipedia, Twitter, Facebook and other social media, saves in Mendeley, CiteULike and other social bookmarks, citations in the scholarly literature, tracked by Web of Science, Scopus, CrossRef, and last not least recommendation for example used by F1000Prime. It is really interesting to visit the list of the top 100 research articles in Altmetric11 in order to see what attracted the public in 2017. Indeed, many of the top themes and topics listed there attach to medical research fields of public interest and do not so intensely represent what is traditionally perceived as highly important scientific work. In any case, we will closely monitor future developments in this sector and make sure that our journal is present, always in parallel with keeping the highest scientific standards. This will never work without you, the cardiovascular scientific community that submits high quality basic and clinical research for publication to our Journal. I am looking forward to a fruitful and enjoyable time as the Editor-in-Chief of the EP-Journal, and I would like to thank once again all of you that have continuously supported the Journal in the past as authors, editors, reviewers, or readers. Please continue to do so in the future! Best personal regards Gerhard Hindricks
No takes yet. Share an insight, caveat, or question.
Gerhard Hindricks (2018) reported an editorial. This editorial reviews the 2017 publication metrics and highlights of the EP Europace Journal, outlining future strategic directions under the new Editor-in-Chief.
Synapse has enriched 10 related papers. Consider them for comparative context: